Tumor-Specific Antigen-Presenting Cell (TSA-APC)

A tumor-specific antigen-presenting cell (APC) refers to a cell that processes and displays antigens derived specifically from tumor cells on its surface, typically via major histocompatibility complex (MHC) molecules. This presentation is crucial for the activation of T cells and the initiation of an adaptive immune response against cancer. Professional APCs include dendritic cells, macrophages, and B lymphocytes; these are specialized in priming antigen-specific T cell responses. Effective recognition of TSAs by APCs is essential for mounting a targeted immune response against tumors. Defects in antigen processing or presentation machinery can allow tumors to evade immune detection and grow unchecked. Some immunotherapies aim to enhance this process by using artificial APCs loaded with TSAs to prime patient immune systems more effectively against their own cancers. Tumor-specific antigen-presenting mechanisms are central targets for modern immunotherapies such as personalized vaccines or adoptive T-cell therapies.

Other names

Tumor antigen presenting cellNeoantigen presenting cell

N/A